Ingmar Wahlqvist - Profile and Investment Details

Investor Profile

Ingmar Wahlqvist is a Venture Capital, Investor based in Melbourne, Victoria, Australia with a diverse investment portfolio that includes companies such as QUE Oncology, Elastagen, Denteric, MecRx, Spinifex Pharmaceuticals, Schuss Alpine Club, Med-e-Serv Pty Ltd, Heart Metabolics, PolyActiva, Cardiora, Q-Sera, Okogen, Ena Respiratory, G I Therapies, Denteric Pty Ltd, Protego Medical, Vaxxas, Myricx Pharma, Signostics, EBR Systems, Auspherix, Solvanix, MetaBloQ, George Medicines, OccuRx, Global Kinetics Corporation, Melbourne Forum, Athena Medicines, Aravax, Fibrotech Therapeutics, Perx Health, . Over time, Ingmar Wahlqvist has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Ingmar Wahlqvist is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Research and Development, Wellness, Digital Infrastructure, Life Science, Engineering, Social Innovation, Education, Biotechnology, Health and Hospital Services, Neuroscience, Research, Colleges, Health Diagnostics, Social Impact, Digital Health, Higher Education, Renewable Energy, Medical, Information Technology, Therapeutics, Australasia, Pharmaceuticals may find it worthwhile to explore potential connections with Ingmar Wahlqvist, as their portfolio suggests a familiarity and interest in this area.

Understanding Ingmar Wahlqvist’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.